[Weiboxin] Comprehensive Solution for African Swine Fever Testing and Diagnosis

On April 4, 2023, the “African Swine Fever Virus Fluorescent PCR Detection Kit” developed by Guangzhou Weiboxin Biotechnology Co., Ltd. (hereinafter referred to as Weiboxin Biotechnology) successfully passed the stringent quality review conducted by the Veterinary Drug Inspection Institute of the Ministry of Agriculture and Rural Affairs of the People’s Republic of China and was granted a veterinary drug product approval number issued by the Ministry. (Veterinary Drug Registration No. 191438923) 。

Weiboxin Biotechnology has long been committed to research and development in the field of biological diagnostic technologies. This fluorescent PCR assay kit for African swine fever virus is a key component of Weiboxin Biotechnology’s ASF product portfolio, and the product features Fast, convenient, and accurate Its characteristics make it suitable for applications that require rapid results, such as material handling, herd relocation, pig intake, and slaughter, thereby providing a new powerful tool for African swine fever prevention and control and ensuring the quality of meat products across the national meat industry.

The acquisition of a veterinary drug approval number for each product serves as testament to Weiboxin Biotechnology’s strength in biotechnology R&D and application, while also providing robust support for further enhancing virus detection capabilities. Looking ahead, Weiboxin Biotechnology will remain committed to its core mission of “professional animal disease testing and technology-driven healthy livestock farming,” continuously introducing more comprehensive services and higher-quality, innovative diagnostic products to safeguard the healthy development of China’s animal husbandry industry.

When looking for animal disease and pet diagnostic reagents, choose the Weiboxin brand.

Be aware of Weiboxin Bio All products of!

Official consultation phone numbers: 020-66377266 / 135 3988 6748, Ms. Dai

Guangzhou Weiboxin Biotechnology Co., Ltd. is located in the national-level innovation park—Guangzhou Science City. The company is a provincial-level “Little Giant” high-tech enterprise specializing in the forward R&D, manufacturing, sales, and technical services of diagnostic reagents for animal epidemics. It has been recognized as a “Contract-Honoring and Credit-Keeping Enterprise” by Guangdong Province and as a “Provincial Intellectual Property Demonstration Unit.” Additionally, it serves as an industry–university–research collaboration base for Guangdong Food and Drug Vocational College and as an executive director unit of the Veterinary Diagnostic and Biological Products Committee of the Guangdong Society of Animal Husbandry and Veterinary Medicine. The company has been designated as an innovative, high-potential enterprise by multiple research institutions, including the Entrepreneurship College of Jinan University in Guangdong Province, and has been awarded the titles of “Specialized, Refined, Distinctive, and Innovative” enterprise at both municipal and provincial levels. It has also received the “Most Investment-Valuable Enterprise” award and the annual title of “ASF and Swine Disease Testing Service Provider.” Furthermore, its veterinary drug product has been granted an approval number by the Ministry of Agriculture and Rural Affairs: Veterinary Drug Registration No. 191438923 (African Swine Fever Virus Fluorescent PCR Diagnostic Kit). The company won the Excellence Award in the Growth Category of the Biopharmaceutical Industry at the 11th China Innovation and Entrepreneurship Competition, secured the Provincial Second Prize in the Growth Category of the Nanotechnology Industry Technology Competition, and earned the National Third Prize in the Growth Category of the National Finals of the Nanotechnology Industry Technology Innovation Special Competition within the China Innovation and Entrepreneurship Competition. It has consecutively received the A-Level Tax Credit Honor Certificate, the Four-Star Trademark and Brand Certification, and the Two-Integration Management System Assessment Certificate each year. In addition, it holds ISO 9001 International Quality Management System Certification, ISO 14001 International Environmental Management System Certification, and GMP certification from the Ministry of Agriculture. Since its establishment, the company has been granted a total of 24 patents, including 5 invention patents, 15 utility model patents, and 4 design patents, along with more than ten trademarks.

The company boasts robust technical capabilities and a team of world-class professionals, including dozens of masters, doctors, and returnees who studied abroad, as well as numerous senior-title technical experts. Currently, the company’s primary focus is on the research and development of molecular diagnostic reagents. Its core R&D team has developed more than 600 products spanning molecular diagnostics and immunoassays, including public-health–oriented fluorescent PCR test kits, animal disease–control–oriented fluorescent PCR test kits, clinical and research–grade fluorescent quantitative PCR kits, and transgenic–identification test kits (ZL2006). The company has also established a nationwide distribution network covering over ten major cities, such as Beijing, Shanghai, Hangzhou, Nanjing, Xi’an, Chongqing, Lanzhou, Zhengzhou, and Qingdao.

Looking ahead, Weiboxin will remain steadfast in its commitment to continuously enhance product quality and service standards. Leveraging a rapid and efficient research platform and abundant biomedical resources, we will conduct extensive and in-depth R&D and scientific research in the biomedical field, thereby contributing to human health and advancing life sciences. Quality is our lifeline; innovation is our soul. Upholding this guiding principle, we will relentlessly strive to become the premier supplier of rapid diagnostic reagents and instruments.